Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities:
Net loss	$ (7,089)	$ (2,924)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of debt premium, discount and issuance cost	592	456
Provision for credit losses	129	(10)
Changes in deferred tax assets and liabilities	(323)	(121)
Change in allowance for sales returns and volume rebates	(175)	90
Change in inventory reserve	86	294
Change in fair value of derivative liabilities	(192)	224
Stock compensation expense	549	641
Depreciation and amortization	2,069	2,263
Change in right of use assets and lease liabilities	1	160
Changes in operating assets and liabilities:
Accounts receivable – trade	2,947	(2,375)
Inventories	4,735	13,571
Prepaid expenses and other current assets	(1,086)	122
Other assets	22	(229)
Accounts payable and accrued expenses	(8,103)	(13,845)
Other liabilities	3,791	(49)
Deferred revenues	105	(171)
Net cash used in operating activities	(1,942)	(1,903)
Cash flows from investing activities:
Purchases of furniture and fixtures, net	(394)	(81)
Net cash used in investing activities	(394)	(81)
Cash flows from financing activities:
Principal payments on long term debt	(2,307)	(670)
Payments of fixed dividends to Series B Preferred stockholders	(317)	(317)
Net cash used in financing activities	(2,624)	(987)
Effect of foreign currency exchange rates	(481)	(346)
Net decrease in cash and cash equivalents	(5,441)	(3,317)
Cash and cash equivalents, beginning of the period	17,253	14,591
Cash and cash equivalents, end of the period	11,812	11,274
Supplemental cash flow disclosures:
Cash paid for income taxes	101	52
Cash paid for interest	1,806	1,975
Non-cash investing and financing transactions:
Addition of operating lease liabilities	$ 52	$ 26